期刊文献+

外源性转化生长因子-β1复合材料对成骨细胞的影响

下载PDF
导出
摘要 目的研究载有外源性TGF-β1复合材料,在体外对小鼠成骨样细胞系(MC3T3-E1)生物活性的影响。方法将MC3T3-E1接种于96孔板中,分别加入不同浓度TGF-β1溶液(0.2ng/ml,1ng/ml,5ng/ml)和FHA、FA悬浮液的混合溶液,并设置对照组,分别培养1d、3d、5d,用酶联免疫检测仪测定OD值以检测细胞活力。结果各组细胞在3d时均出现成倍增殖,除空白组外5d时均增殖减弱。浓度为1ng/ml TGF-β1比0.2ng/ml和5ng/ml具有更强的促成骨细胞增殖作用。结论 TGF-β1与FHA、FA的混合溶液可改变成骨细胞增殖周期,使之提前出现增殖高峰,且1ng/ml TGF-β1溶液对成骨细胞具有最强的促增殖作用。 Objective Research the biological activity of exogenous TGF-β1 composite materials in vitro and its effect on signal expression of osteoblastic cell(MC3T3-E1). Methods MC3T3-E1 was seeded in 96-well plates,and added to mixed solution with different concentrations of TGF-β1 solution(0.2,1,5 ng / ml)and FHA,FA suspension, and control groups were set up. The groups were cultured 1d,3d,5d,and then OD values measured by enzyme-linked immunosorbent assay to detect cell viability. Results Cells of each group proliferated visibly in 3d,and decreased slightly in 5d except the blank,the concentration of 1ng/ml TGF-β1 had stronger promotion than 0.2ng/ml and 5ng/ml on cell proliferation. Conclusion Mixed solution with TGF-β1 and FHA、FA suspension can alter the proliferation cycle of osteoblasts,and advance the peak of proliferation. 1ng/ml TGF-β1 solution has the strongest effect on the proliferation of osteoblasts.
出处 《浙江临床医学》 2013年第8期1108-1112,共5页 Zhejiang Clinical Medical Journal
关键词 TGF-β1 含氟羟基磷灰石 氟磷灰石 成骨细胞 骨再生 TGF- β1 Fluor-hydroxyapatite fluorapatite Osteoblast Bone regeneration
  • 相关文献

参考文献17

二级参考文献31

  • 1柴本甫,汤雪明,徐荣辉.家兔皮肤成纤维细胞的成骨潜能(组织化学及放射自显影研究)[J].中华骨科杂志,1994,14(11):682-685. 被引量:13
  • 2丛笑倩,姚鑫.ES细胞分化为血管样结构的机理探讨—TGF-β1在血管形成中的作用[J].实验生物学报,1996,29(3):273-286. 被引量:23
  • 3Jeffcoat MK,Chesnut CH 3rd.Systemic osteoporosis and oral bone loss:Evidence shows increased risk faetors[J].J Am Dent Assoc,1993,124(11):49-56.
  • 4Becker W,Hujoel PP,Becker BE,et al.Osteoporosis and implant failure:An exploratory case-control study[J].J Peiodontol,2000,71(4):625-631.
  • 5Pacifici R.Estrogen,cytokine and pathogenesis of postmeno pansal osteopomsis[J].J Bone Miner Res,1996,11(8):1043-1051.
  • 6Weide R,Ehlenz K,Lorenz W,et al.Successful treatment of osteoporosis in systemic mastoeytosis with interferon alpha-2b[J].Ann Hematol,1996,72(1):41-43.
  • 7Carswell EA,Old LJ,Kassel RL,et al.An endotoxin-induced serum factor that causes necrosis of tumors[J].Proc Natl Acad Sci U S A,1975,72(9):3666-3670.
  • 8Pfeilschifter J,Koditz R,Pfohl M,et al.Changes in proinflammatory cytokine activity after menopause[J].Endocr Rev,2002,23(1):90-119.
  • 9Cirasole G,Giuliani N,Modena AB,et al.Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro[J].Clin Endocrinol(Oxf),1999,5(6):801-807.
  • 10Leiding-Bruckner G,Ziegler R.Diabetes mellitus a risk for osteoporosis[J].Exp Clin Endocrinol Diabetes,2001,109(Suppl 2):S493-S514.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部